BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31710795)

  • 1. Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality.
    Young KA; Regan EA; Han MK; Lutz SM; Ragland M; Castaldi PJ; Washko GR; Cho MH; Strand M; Curran-Everett D; Beaty TH; Bowler RP; Wan ES; Lynch DA; Make BJ; Silverman EK; Crapo JD; Hokanson JE; Kinney GL;
    Chronic Obstr Pulm Dis; 2019 Nov; 6(5):400-413. PubMed ID: 31710795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Subtypes Exhibit Differential Global Initiative for Chronic Obstructive Lung Disease Spirometry Stage Progression: The COPDGene® Study.
    Young KA; Strand M; Ragland MF; Kinney GL; Austin EE; Regan EA; Lowe KE; Make BJ; Silverman EK; Crapo JD; Hokanson JE;
    Chronic Obstr Pulm Dis; 2019 Nov; 6(5):414-429. PubMed ID: 31710796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity and Progression of Chronic Obstructive Pulmonary Disease: Emphysema-Predominant and Non-Emphysema-Predominant Disease.
    Castaldi PJ; Xu Z; Young KA; Hokanson JE; Lynch DA; Humphries SM; Ross JC; Cho MH; Hersh CP; Crapo JD; Strand M; Silverman EK
    Am J Epidemiol; 2023 Oct; 192(10):1647-1658. PubMed ID: 37160347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPDGene
    Lowe KE; Regan EA; Anzueto A; Austin E; Austin JHM; Beaty TH; Benos PV; Benway CJ; Bhatt SP; Bleecker ER; Bodduluri S; Bon J; Boriek AM; Boueiz AR; Bowler RP; Budoff M; Casaburi R; Castaldi PJ; Charbonnier JP; Cho MH; Comellas A; Conrad D; Costa Davis C; Criner GJ; Curran-Everett D; Curtis JL; DeMeo DL; Diaz AA; Dransfield MT; Dy JG; Fawzy A; Fleming M; Flenaugh EL; Foreman MG; Fortis S; Gebrekristos H; Grant S; Grenier PA; Gu T; Gupta A; Han MK; Hanania NA; Hansel NN; Hayden LP; Hersh CP; Hobbs BD; Hoffman EA; Hogg JC; Hokanson JE; Hoth KF; Hsiao A; Humphries S; Jacobs K; Jacobson FL; Kazerooni EA; Kim V; Kim WJ; Kinney GL; Koegler H; Lutz SM; Lynch DA; MacIntye NR; Make BJ; Marchetti N; Martinez FJ; Maselli DJ; Mathews AM; McCormack MC; McDonald MN; McEvoy CE; Moll M; Molye SS; Murray S; Nath H; Newell JD; Occhipinti M; Paoletti M; Parekh T; Pistolesi M; Pratte KA; Putcha N; Ragland M; Reinhardt JM; Rennard SI; Rosiello RA; Ross JC; Rossiter HB; Ruczinski I; San Jose Estepar R; Sciurba FC; Sieren JC; Singh H; Soler X; Steiner RM; Strand MJ; Stringer WW; Tal-Singer R; Thomashow B; Vegas Sánchez-Ferrero G; Walsh JW; Wan ES; Washko GR; Michael Wells J; Wendt CH; Westney G; Wilson A; Wise RA; Yen A; Young K; Yun J; Silverman EK; Crapo JD
    Chronic Obstr Pulm Dis; 2019 Nov; 6(5):384-399. PubMed ID: 31710793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers.
    Gregory A; Xu Z; Pratte K; Lee S; Liu C; Chase R; Yun J; Saferali A; Hersh CP; Bowler R; Silverman E; Castaldi PJ; Boueiz A
    BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 35999035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
    Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
    Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarkers predict disease severity, progression and mortality in COPD.
    Zemans RL; Jacobson S; Keene J; Kechris K; Miller BE; Tal-Singer R; Bowler RP
    Respir Res; 2017 Jun; 18(1):117. PubMed ID: 28610627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.
    Ragland MF; Strand M; Baraghoshi D; Young KA; Kinney GL; Austin E; Hokanson JE; Regan E; Crapo J; Silverman EK; Make B
    Ann Am Thorac Soc; 2022 Mar; 19(3):381-388. PubMed ID: 34461026
    [No Abstract]   [Full Text] [Related]  

  • 10. Subtyping COPD by Using Visual and Quantitative CT Imaging Features.
    Park J; Hobbs BD; Crapo JD; Make BJ; Regan EA; Humphries S; Carey VJ; Lynch DA; Silverman EK;
    Chest; 2020 Jan; 157(1):47-60. PubMed ID: 31283919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.
    Lee JH; Cho MH; McDonald ML; Hersh CP; Castaldi PJ; Crapo JD; Wan ES; Dy JG; Chang Y; Regan EA; Hardin M; DeMeo DL; Silverman EK;
    Respir Med; 2014 Oct; 108(10):1469-80. PubMed ID: 25154699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.
    Schroeder JD; McKenzie AS; Zach JA; Wilson CG; Curran-Everett D; Stinson DS; Newell JD; Lynch DA
    AJR Am J Roentgenol; 2013 Sep; 201(3):W460-70. PubMed ID: 23971478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsupervised Learning Identifies Computed Tomographic Measurements as Primary Drivers of Progression, Exacerbation, and Mortality in Chronic Obstructive Pulmonary Disease.
    Yuan NF; Hasenstab K; Retson T; Conrad DJ; Lynch DA; Hsiao A
    Ann Am Thorac Soc; 2022 Dec; 19(12):1993-2002. PubMed ID: 35830591
    [No Abstract]   [Full Text] [Related]  

  • 14. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.
    Castaldi PJ; Dy J; Ross J; Chang Y; Washko GR; Curran-Everett D; Williams A; Lynch DA; Make BJ; Crapo JD; Bowler RP; Regan EA; Hokanson JE; Kinney GL; Han MK; Soler X; Ramsdell JW; Barr RG; Foreman M; van Beek E; Casaburi R; Criner GJ; Lutz SM; Rennard SI; Santorico S; Sciurba FC; DeMeo DL; Hersh CP; Silverman EK; Cho MH
    Thorax; 2014 May; 69(5):415-22. PubMed ID: 24563194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a method to assess emphysema severity by spirometry in the COPDGene study.
    Occhipinti M; Paoletti M; Crapo JD; Make BJ; Lynch DA; Brusasco V; Lavorini F; Silverman EK; Regan EA; Pistolesi M
    Respir Res; 2020 May; 21(1):103. PubMed ID: 32357885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
    Labaki WW; Gu T; Murray S; Curtis JL; Wells JM; Bhatt SP; Bon J; Diaz AA; Hersh CP; Wan ES; Kim V; Beaty TH; Hokanson JE; Bowler RP; Arenberg DA; Kazerooni EA; Martinez FJ; Silverman EK; Crapo JD; Make BJ; Regan EA; Han MK; ;
    Am J Respir Crit Care Med; 2023 Aug; 208(4):451-460. PubMed ID: 37159910
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
    Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
    Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting COPD Progression in Current and Former Smokers Using a Joint Model for Forced Expiratory Volume in 1 Second and Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio.
    Strand M; Khatiwada A; Baraghoshi D; Lynch D; Silverman EK; Bhatt SP; Austin E; Regan EA; Boriek AM; Crapo JD
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):439-453. PubMed ID: 35905755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung volumes differentiate the predominance of emphysema
    Zeng S; Luo G; Lynch DA; Bowler RP; Arjomandi M
    ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37727675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.